359 related articles for article (PubMed ID: 33394574)
1. Leptomeningeal Spread in Glioblastoma: Diagnostic and Therapeutic Challenges.
Birzu C; Tran S; Bielle F; Touat M; Mokhtari K; Younan N; Psimaras D; Hoang-Xuan K; Sanson M; Delattre JY; Idbaih A
Oncologist; 2020 Nov; 25(11):e1763-e1776. PubMed ID: 33394574
[TBL] [Abstract][Full Text] [Related]
2. Optimal treatment of leptomeningeal spread in glioblastoma: analysis of risk factors and outcome.
Noh JH; Lee MH; Kim WS; Lim DH; Kim ST; Kong DS; Nam DH; Lee JI; Seol HJ
Acta Neurochir (Wien); 2015 Apr; 157(4):569-76. PubMed ID: 25663100
[TBL] [Abstract][Full Text] [Related]
3. Leptomeningeal spread in high-grade gliomas: Is surgery or adjuvant therapy after leptomeningeal spread associated with survival benefit?
Zhong S; Fu X; Wu C; Liu R; Li S
Neurosurg Rev; 2023 Nov; 46(1):311. PubMed ID: 37993665
[TBL] [Abstract][Full Text] [Related]
4. Leptomeningeal Spread at the Diagnosis of Glioblastoma Multiforme: A Case Report and Literature Review.
Jang C; Cho BK; Hwang SH; Shin HJ; Yoon SH
Brain Tumor Res Treat; 2022 Jul; 10(3):183-189. PubMed ID: 35929116
[TBL] [Abstract][Full Text] [Related]
5. Epithelioid/rhabdoid glioblastoma: a highly aggressive subtype of glioblastoma.
Sugimoto K; Ideguchi M; Kimura T; Kajiwara K; Imoto H; Sadahiro H; Ishii A; Kawano H; Ikeda E; Suzuki M
Brain Tumor Pathol; 2016 Apr; 33(2):137-46. PubMed ID: 26667174
[TBL] [Abstract][Full Text] [Related]
6. Adult Glioblastoma.
Alexander BM; Cloughesy TF
J Clin Oncol; 2017 Jul; 35(21):2402-2409. PubMed ID: 28640706
[TBL] [Abstract][Full Text] [Related]
7. Treatment options for progression or recurrence of glioblastoma: a network meta-analysis.
McBain C; Lawrie TA; Rogozińska E; Kernohan A; Robinson T; Jefferies S
Cochrane Database Syst Rev; 2021 May; 5(1):CD013579. PubMed ID: 34559423
[TBL] [Abstract][Full Text] [Related]
8. A systematic review of multifocal and multicentric glioblastoma.
Li Y; Zhang ZX; Huang GH; Xiang Y; Yang L; Pei YC; Yang W; Lv SQ
J Clin Neurosci; 2021 Jan; 83():71-76. PubMed ID: 33358091
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and Therapeutic Biomarkers in Glioblastoma: Current Status and Future Perspectives.
Szopa W; Burley TA; Kramer-Marek G; Kaspera W
Biomed Res Int; 2017; 2017():8013575. PubMed ID: 28316990
[TBL] [Abstract][Full Text] [Related]
10. Leptomeningeal disease in glioblastoma: endgame or opportunity?
Akmal S; Ginalis EE; Patel NV; Aiken R; Dicpinigaitis AJ; Hanft SJ
J Neurooncol; 2021 Nov; 155(2):107-115. PubMed ID: 34623599
[TBL] [Abstract][Full Text] [Related]
11. Leptomeningeal spinal metastases from glioblastoma multiforme: treatment and management of an uncommon manifestation of disease.
Lawton CD; Nagasawa DT; Yang I; Fessler RG; Smith ZA
J Neurosurg Spine; 2012 Nov; 17(5):438-48. PubMed ID: 22958073
[TBL] [Abstract][Full Text] [Related]
12. Clinical features associated with the efficacy of chemotherapy in patients with glioblastoma (GBM): a surveillance, epidemiology, and end results (SEER) analysis.
Wen J; Chen W; Zhu Y; Zhang P
BMC Cancer; 2021 Jan; 21(1):81. PubMed ID: 33468109
[TBL] [Abstract][Full Text] [Related]
13. Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of emerging developments in the management of newly diagnosed glioblastoma.
Farrell C; Shi W; Bodman A; Olson JJ
J Neurooncol; 2020 Nov; 150(2):269-359. PubMed ID: 33215345
[TBL] [Abstract][Full Text] [Related]
14. Novel sights on therapeutic, prognostic, and diagnostics aspects of non-coding RNAs in glioblastoma multiforme.
Mekala JR; Adusumilli K; Chamarthy S; Angirekula HSR
Metab Brain Dis; 2023 Aug; 38(6):1801-1829. PubMed ID: 37249862
[TBL] [Abstract][Full Text] [Related]
15. Treatment options and outcomes for glioblastoma in the elderly patient.
Arvold ND; Reardon DA
Clin Interv Aging; 2014; 9():357-67. PubMed ID: 24591820
[TBL] [Abstract][Full Text] [Related]
16. Advances and challenges in the treatment of glioblastoma: a clinician's perspective.
Mrugala MM
Discov Med; 2013 Apr; 15(83):221-30. PubMed ID: 23636139
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics and neuroimaging findings in 12 cases of recurrent glioblastoma with communicating hydrocephalus.
Onuma K; Ishikawa E; Matsuda M; Hirata K; Osuka S; Yamamoto T; Masumoto T; Zaboronok A; Matsumura A
Neurol Med Chir (Tokyo); 2013; 53(7):474-81. PubMed ID: 23883558
[TBL] [Abstract][Full Text] [Related]
18. Glioblastoma: Overview of Disease and Treatment.
Davis ME
Clin J Oncol Nurs; 2016 Oct; 20(5 Suppl):S2-8. PubMed ID: 27668386
[TBL] [Abstract][Full Text] [Related]
19. Glioblastoma multiforme: a review of therapeutic targets.
Kanu OO; Mehta A; Di C; Lin N; Bortoff K; Bigner DD; Yan H; Adamson DC
Expert Opin Ther Targets; 2009 Jun; 13(6):701-18. PubMed ID: 19409033
[TBL] [Abstract][Full Text] [Related]
20. Disparities in health care determine prognosis in newly diagnosed glioblastoma.
Chandra A; Rick JW; Dalle Ore C; Lau D; Nguyen AT; Carrera D; Bonte A; Molinaro AM; Theodosopoulos PV; McDermott MW; Berger MS; Aghi MK
Neurosurg Focus; 2018 Jun; 44(6):E16. PubMed ID: 29852776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
